Literature DB >> 25231070

Rhamnolipids elicit the same cytotoxic sensitivity between cancer cell and normal cell by reducing surface tension of culture medium.

Lifang Jiang1, Chong Shen, Xuwei Long, Guoliang Zhang, Qin Meng.   

Abstract

Biosurfactant rhamnolipids have been claimed to show biological activities of inhibiting the proliferation of cancer cells. In this study, the cytotoxicity of rhamnolipids was examined on four cancer cells (HepG2, Caco-2, Hela, MCF-7 cells) and two normal cells (HK-2 cell, primary hepatocyte). Interestingly, both cancer cells and normal cells exhibited similar sensitivities to the addition of rhamnolipids in culture medium, and the cytotoxicity was largely attenuated by the presence of fetal bovine serum (FBS) in culture medium. In correlation of the mono-/di-rhamnolipid cytotoxicity with the surface tension of culture medium, it was found that rhamnolipids triggered cytotoxicity whenever the surface tension of culture medium decreased below 41 mN/m irrespective of the FBS content in culture medium, cell line, or rhamnolipid congener. Similarly, each chemical surfactant (Tween-80, sodium dodecyl sulfate, and sodium dodecyl benzene sulfonate) could cause cytotoxicity on HepG2 cells whenever its addition made the surface tension under 41 mN/m in culture medium with or without the presence of FBS. It seems that rhamnolipids, like chemical surfactants, exhibited cytotoxicity by reducing the surface tension of culture medium rather than by changing its specific molecular structure, which had no selection on tumor cells. This study could offer helps to correct the misleading biological activity of rhamnolipids and to avoid the possible large wastes of time and expenses on developing the applications in antitumor drugs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25231070     DOI: 10.1007/s00253-014-6065-0

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  10 in total

1.  The Use of Surfactants to Solubilise a Glucagon Analogue.

Authors:  Jens Kvist Madsen; Lise Giehm; Daniel E Otzen
Journal:  Pharm Res       Date:  2018-10-15       Impact factor: 4.200

2.  Rhamnolipid-Based Liposomes as Promising Nano-Carriers for Enhancing the Antibacterial Activity of Peptides Derived from Bacterial Toxin-Antitoxin Systems.

Authors:  Beatriz Cristina Pecoraro Sanches; Camila Aguiar Rocha; Jose Gregorio Martin Bedoya; Vinicius Luiz da Silva; Patrícia Bento da Silva; Ana Marisa Fusco-Almeida; Marlus Chorilli; Jonas Contiero; Edson Crusca; Reinaldo Marchetto
Journal:  Int J Nanomedicine       Date:  2021-02-10

3.  Targeted killing of myofibroblasts by biosurfactant di-rhamnolipid suggests a therapy against scar formation.

Authors:  Chong Shen; Lifang Jiang; Huawei Shao; Chuangang You; Guoliang Zhang; Sitong Ding; Tingwei Bian; Chunmao Han; Qin Meng
Journal:  Sci Rep       Date:  2016-11-30       Impact factor: 4.379

4.  Anti-biofilm Properties of Bacterial Di-Rhamnolipids and Their Semi-Synthetic Amide Derivatives.

Authors:  Ivana Aleksic; Milos Petkovic; Milos Jovanovic; Dusan Milivojevic; Branka Vasiljevic; Jasmina Nikodinovic-Runic; Lidija Senerovic
Journal:  Front Microbiol       Date:  2017-12-08       Impact factor: 5.640

5.  High Di-rhamnolipid Production Using Pseudomonas aeruginosa KT1115, Separation of Mono/Di-rhamnolipids, and Evaluation of Their Properties.

Authors:  Jie Zhou; Rui Xue; Shixun Liu; Ning Xu; Fengxue Xin; Wenming Zhang; Min Jiang; Weiliang Dong
Journal:  Front Bioeng Biotechnol       Date:  2019-10-22

Review 6.  Antimicrobial Properties of Chitosan and Chitosan Derivatives in the Treatment of Enteric Infections.

Authors:  Dazhong Yan; Yanzhen Li; Yinling Liu; Na Li; Xue Zhang; Chen Yan
Journal:  Molecules       Date:  2021-11-25       Impact factor: 4.411

7.  Rhamnolipids Nano-Micelles as a Potential Hand Sanitizer.

Authors:  Marwa Reda Bakkar; Ahmed Hassan Ibrahim Faraag; Elham R S Soliman; Manar S Fouda; Amir Mahfouz Mokhtar Sarguos; Gary R McLean; Ali M S Hebishy; Gehad E Elkhouly; Nermeen R Raya; Yasmin Abo-Zeid
Journal:  Antibiotics (Basel)       Date:  2021-06-22

8.  Characterization of Rhamnolipids Produced by an Arctic Marine Bacterium from the Pseudomonas fluorescence Group.

Authors:  Venke Kristoffersen; Teppo Rämä; Johan Isaksson; Jeanette Hammer Andersen; William H Gerwick; Espen Hansen
Journal:  Mar Drugs       Date:  2018-05-14       Impact factor: 5.118

9.  Chemical synthesis and cytotoxicity of neo-glycolipids; rare sugar-glycerol-lipid compounds.

Authors:  Keisuke Hirata; Takashi Uchida; Yoshikata Nakajima; Toru Maekawa; Toru Mizuki
Journal:  Heliyon       Date:  2018-10-17

10.  Characterization and Cytotoxicity of Pseudomonas Mediated Rhamnolipids Against Breast Cancer MDA-MB-231 Cell Line.

Authors:  Neelam Mishra; Kavita Rana; Siva Deepthi Seelam; Rakesh Kumar; Vijyendra Pandey; Bharathi P Salimath; Dayanand Agsar
Journal:  Front Bioeng Biotechnol       Date:  2021-11-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.